These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

595 related articles for article (PubMed ID: 24814343)

  • 1. CFIm25 links alternative polyadenylation to glioblastoma tumour suppression.
    Masamha CP; Xia Z; Yang J; Albrecht TR; Li M; Shyu AB; Li W; Wagner EJ
    Nature; 2014 Jun; 510(7505):412-6. PubMed ID: 24814343
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Driving glioblastoma growth by alternative polyadenylation.
    Han T; Kim JK
    Cell Res; 2014 Sep; 24(9):1023-4. PubMed ID: 24993033
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of cleavage factor Im 25 promotes the proliferation of lung cancer cells through alternative polyadenylation.
    Huang J; Weng T; Ko J; Chen NY; Xiang Y; Volcik K; Han L; Blackburn MR; Lu X
    Biochem Biophys Res Commun; 2018 Sep; 503(2):856-862. PubMed ID: 29928883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Cancer-Specific Ubiquitin Ligase Drives mRNA Alternative Polyadenylation by Ubiquitinating the mRNA 3' End Processing Complex.
    Yang SW; Li L; Connelly JP; Porter SN; Kodali K; Gan H; Park JM; Tacer KF; Tillman H; Peng J; Pruett-Miller SM; Li W; Potts PR
    Mol Cell; 2020 Mar; 77(6):1206-1221.e7. PubMed ID: 31980388
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nudt21 regulates the alternative polyadenylation of Pak1 and is predictive in the prognosis of glioblastoma patients.
    Chu Y; Elrod N; Wang C; Li L; Chen T; Routh A; Xia Z; Li W; Wagner EJ; Ji P
    Oncogene; 2019 May; 38(21):4154-4168. PubMed ID: 30705404
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CFIm25 and alternative polyadenylation: Conflicting roles in cancer.
    Jafari Najaf Abadi MH; Shafabakhsh R; Asemi Z; Mirzaei HR; Sahebnasagh R; Mirzaei H; Hamblin MR
    Cancer Lett; 2019 Sep; 459():112-121. PubMed ID: 31181319
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CFIm25 regulates human stem cell function independently of its role in mRNA alternative polyadenylation.
    Ran Y; Huang S; Shi J; Feng Q; Deng Y; Xiang AP; Yao C
    RNA Biol; 2022; 19(1):686-702. PubMed ID: 35491945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NUDT21 negatively regulates PSMB2 and CXXC5 by alternative polyadenylation and contributes to hepatocellular carcinoma suppression.
    Tan S; Li H; Zhang W; Shao Y; Liu Y; Guan H; Wu J; Kang Y; Zhao J; Yu Q; Gu Y; Ding K; Zhang M; Qian W; Zhu Y; Cai H; Chen C; Lobie PE; Zhao X; Sun J; Zhu T
    Oncogene; 2018 Aug; 37(35):4887-4900. PubMed ID: 29780166
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knock-down of 25 kDa subunit of cleavage factor Im in Hela cells alters alternative polyadenylation within 3'-UTRs.
    Kubo T; Wada T; Yamaguchi Y; Shimizu A; Handa H
    Nucleic Acids Res; 2006; 34(21):6264-71. PubMed ID: 17098938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The emerging roles of CFIm25 (NUDT21/CPSF5) in human biology and disease.
    Masamha CP
    Wiley Interdiscip Rev RNA; 2023; 14(3):e1757. PubMed ID: 35965101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Implications of polyadenylation in health and disease.
    Curinha A; Oliveira Braz S; Pereira-Castro I; Cruz A; Moreira A
    Nucleus; 2014; 5(6):508-19. PubMed ID: 25484187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of alternative polyadenylation by the C2H2-zinc-finger protein Sp1.
    Song J; Nabeel-Shah S; Pu S; Lee H; Braunschweig U; Ni Z; Ahmed N; Marcon E; Zhong G; Ray D; Ha KCH; Guo X; Zhang Z; Hughes TR; Blencowe BJ; Greenblatt JF
    Mol Cell; 2022 Sep; 82(17):3135-3150.e9. PubMed ID: 35914531
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involved microRNAs in alternative polyadenylation intervene in breast cancer via regulation of cleavage factor "CFIm25".
    Tamaddon M; Shokri G; Hosseini Rad SMA; Rad I; Emami Razavi À; Kouhkan F
    Sci Rep; 2020 Jul; 10(1):11608. PubMed ID: 32665581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of CFIm25 amplifies dermal fibrosis through alternative polyadenylation.
    Weng T; Huang J; Wagner EJ; Ko J; Wu M; Wareing NE; Xiang Y; Chen NY; Ji P; Molina JG; Volcik KA; Han L; Mayes MD; Blackburn MR; Assassi S
    J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31757866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-181a promotes proliferation and inhibits apoptosis by suppressing CFIm25 in osteosarcoma.
    Zhu ZJ; Huang P; Chong YX; Kang LX; Huang X; Zhu ZX; Nie L
    Mol Med Rep; 2016 Nov; 14(5):4271-4278. PubMed ID: 27633853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Downregulation of CPSF6 leads to global mRNA 3' UTR shortening and enhanced antiviral immune responses.
    Ge Y; Huang J; Chen R; Fu Y; Ling T; Ou X; Rong X; Cheng Y; Lin Y; Zhou F; Lu C; Yuan S; Xu A
    PLoS Pathog; 2024 Feb; 20(2):e1012061. PubMed ID: 38416782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage factor 25 deregulation contributes to pulmonary fibrosis through alternative polyadenylation.
    Weng T; Ko J; Masamha CP; Xia Z; Xiang Y; Chen NY; Molina JG; Collum S; Mertens TC; Luo F; Philip K; Davies J; Huang J; Wilson C; Thandavarayan RA; Bruckner BA; Jyothula SS; Volcik KA; Li L; Han L; Li W; Assassi S; Karmouty-Quintana H; Wagner EJ; Blackburn MR
    J Clin Invest; 2019 May; 129(5):1984-1999. PubMed ID: 30830875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ubiquitously transcribed genes use alternative polyadenylation to achieve tissue-specific expression.
    Lianoglou S; Garg V; Yang JL; Leslie CS; Mayr C
    Genes Dev; 2013 Nov; 27(21):2380-96. PubMed ID: 24145798
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Poly(A)-ClickSeq: click-chemistry for next-generation 3΄-end sequencing without RNA enrichment or fragmentation.
    Routh A; Ji P; Jaworski E; Xia Z; Li W; Wagner EJ
    Nucleic Acids Res; 2017 Jul; 45(12):e112. PubMed ID: 28449108
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CPSF6 links alternative polyadenylation to metabolism adaption in hepatocellular carcinoma progression.
    Tan S; Zhang M; Shi X; Ding K; Zhao Q; Guo Q; Wang H; Wu Z; Kang Y; Zhu T; Sun J; Zhao X
    J Exp Clin Cancer Res; 2021 Mar; 40(1):85. PubMed ID: 33648552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 30.